Area of research
Oncology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Viral Infections and Immunology Research, Extracellular vesicles in disease, and Esophageal Cancer Research and Treatment.
Multi-omics analysis of host airway responses in pediatric Mycoplasma pneumoniae pneumonia reveals potential mechanisms of disease exacerbation caused by co-infection
Esophageal squamous cell carcinoma derived sEV-PDL1 exhausts CD8+T cells to promote immunosuppression
Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis–Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation
Acidity-activatable dynamic hybrid nanoplatforms derived from extracellular vesicles of M1 macrophages enhance cancer immunotherapy through synergistic triple immunotherapy
Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death
Distinguishing optimal candidates for primary tumor resection in patients with metastatic lung adenocarcinoma: A predictive model based on propensity score matching
Role of exosomes in prostate cancer bone metastasis
Esophageal cancer cell-derived small extracellular vesicles decrease circulating Tfh/Tfr via sEV-PDL1 to promote immunosuppression
Determination of synephrine in herbal plants using an isotopically labeled internal standard HPLC–MS/MS method
Esophageal cancer-derived exosomes imbalance Tfh/Tfr cell ratio in the tumor immune microenvironment via EXO-PDL1 to promote immunosuppression
Esophageal cancer derived exosomes imbalance circulating Tfh/Tfr via EXO-PDL1 to promote immunosuppression
Esophageal Cancer Cell-Derived Exosomes Decrease Circulating Tfh/Tfr Via Exo-Pdl1 to Promote Immunosuppression
SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination